(Q69063905)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

main subject

phase I clinical trial

1 reference

W N Hait

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

S Morris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

J S Lazo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

R J Figlin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

H J Durivage

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

K White

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

P E Schwartz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

29 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

358-362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00435836

29 September 2019

exact match

0 references

cites work

A clinical review of bleomycin--a new antineoplastic agent

1 reference

12 December 2020

Chemical modulation of bleomycin induced toxicity

1 reference

12 December 2020

Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin.

1 reference

12 December 2020

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

1 reference

12 December 2020

Phosphodiesterase protein activator mimics red blood cell cytoplasmic activator of (Ca2+-Mg2+)ATPase

1 reference

12 December 2020

Identification of the Ca2+-dependent modulator protein as the fourth subunit of rabbit skeletal muscle phosphorylase kinase

1 reference

12 December 2020

Control of microtubule assembly-disassembly by calcium-dependent regulator protein

1 reference

12 December 2020

Increased lethality of calmodulin antagonists and bleomycin to human bone marrow and bleomycin-resistant malignant cells.

1 reference

12 December 2020

Ca-calmodulin mediates the DNA-synthetic response of calcium-deprived liver cells to the tumor promoter TPA

1 reference

12 December 2020

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy

1 reference

12 December 2020

Calmodulin Plays a Pivotal Role in Cellular Regulation

1 reference

12 December 2020

Calmodulin stimulates DNA synthesis by rat liver cells

1 reference

12 December 2020

Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin

1 reference

12 December 2020

Combined total body electron beam irradiation and chemotherapy for mycosis fungoides

1 reference

12 December 2020

Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists

1 reference

12 December 2020

Antitumor and toxic effects of combination chemotherapy with bleomycin and a phenothiazine anticalmodulin agent

1 reference

12 December 2020

Ca2+-dependent protein phosphorylation system in membranes from various tissues, and its activation by "calcium-dependent regulator"

1 reference

12 December 2020

Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists.

1 reference

12 December 2020

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer

1 reference

12 December 2020

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil

1 reference

12 December 2020

Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.

1 reference

12 December 2020

Calmodulin: a potential target for cancer chemotherapeutic agents

1 reference

12 December 2020

Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain

1 reference

12 December 2020

Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13

1 reference

12 December 2020

Partial purification of the Ca2+-Mg2+ ATPase activator from human erythrocytes: Its similarity to the activator of 3′:5′ — cyclic nucleotide phosphodiesterase

1 reference

12 December 2020

Calcineurin is a calmodulin-dependent protein phosphatase.

1 reference

12 December 2020

Potentiation of Bleomycin Lethality by Anticalmodulin Drugs: A Role for Calmodulin in DNA Repair

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00435836

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2469543%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 September 2019

0 references

1 reference